Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1 clinical trials
A Comparison of Rocuronium 0.6 mg/kg and Remifentanil 2 g/kg in Elderly Patients Over 80 Years

There is no risk of residual neuromuscular block, nonetheless circulatory side effects have been seen. It is unknown which is superior concerning intubating conditions in elderly patients.

neuromuscular blockade
intubation
neuromuscular blocking agents
residual block
rocuronium
  • 0 views
  • 16 Feb, 2024
  • 2 locations